Trinity Biotech Announces That It Has Received 510(k) Clearance From The FDA For The Premier Resolution System
Portfolio Pulse from Benzinga Newsdesk
Trinity Biotech has received 510(k) clearance from the FDA for the Premier Resolution System. This approval allows the company to market and sell the product in the United States.
August 07, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Trinity Biotech's stock may see positive movement following the FDA's 510(k) clearance for the Premier Resolution System.
The FDA's 510(k) clearance is a significant regulatory milestone that allows Trinity Biotech to market and sell the Premier Resolution System in the United States. This could potentially increase the company's revenues and positively impact its stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100